A Ruffault - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A Ruffault

Showing results (21-30 of 38) with videos related to

Pageof 4

Sort By:

Journal of Virological Methods|April 26, 1996

New types of primers (stair primers) for PCR amplification of the variable V3 region of the human immunodeficiency virusR Colimon, S Minjolle, P André, et al.

Lancet (London, England)|September 13, 1986

Transmissibility of human immunodeficiency virus in haemophilic and non-haemophilic children living in a private school in FranceA Berthier, S Chamaret, R Fauchet, et al.

Human Reproduction (Oxford, England)|June 24, 2008

Antiviral responses of human Leydig cells to mumps virus infection or poly I:C stimulationA Le Tortorec, H Denis, A-P Satie, et al.

Journal of Interferon Research|May 1, 1992

Interferon production in severe hemophiliacs with and without HIV antibodiesA Ruffault, N Genetet, A M Berthier, et al.

Journal of Interferon Research|February 1, 1988

Interferon production in severe hemophiliacs with and without HIV antibodiesA Ruffault, N Genetet, A M Berthier, et al.

Virologie (Montrouge, France)|November 4, 2021

[HIV1 group M superinfection in a HIV1 group0-infected patient]J-C Plantier, V Lemée, I Dorval, et al.

Hepatology (Baltimore, Md.)|February 1, 1995

Interferon and ursodeoxycholic acid combined therapy in the treatment of chronic viral C hepatitis: results from a controlled randomized trial in 80 patientsE Boucher, H Jouanolle, P Andre, et al.

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1995

Genotypic evolution of HIV-1 isolates from patients after a switch of therapy from zidovudine to didanosineB Masquelier, I Pellegrin, A Ruffault, et al.

Journal of Neurovirology|December 5, 1998

Prevalence of JC virus viraemia in HIV-infected patients with or without neurological disorders: a prospective studyV Dubois, H Moret, M E Lafon, et al.

The Journal of Infectious Diseases|December 9, 2000

JC virus genotypes in France: molecular epidemiology and potential significance for progressive multifocal leukoencephalopathyV Dubois, H Moret, M E Lafon, et al.

Pageof 4

Search research articles

Showing results (21-30 of 38) with videos related to

Sort By:

Pageof 4

Journal of Virological Methods|April 26, 1996

New types of primers (stair primers) for PCR amplification of the variable V3 region of the human immunodeficiency virusR Colimon, S Minjolle, P André, et al.

Lancet (London, England)|September 13, 1986

Transmissibility of human immunodeficiency virus in haemophilic and non-haemophilic children living in a private school in FranceA Berthier, S Chamaret, R Fauchet, et al.

Human Reproduction (Oxford, England)|June 24, 2008

Antiviral responses of human Leydig cells to mumps virus infection or poly I:C stimulationA Le Tortorec, H Denis, A-P Satie, et al.

Journal of Interferon Research|May 1, 1992

Interferon production in severe hemophiliacs with and without HIV antibodiesA Ruffault, N Genetet, A M Berthier, et al.

Journal of Interferon Research|February 1, 1988

Interferon production in severe hemophiliacs with and without HIV antibodiesA Ruffault, N Genetet, A M Berthier, et al.

Virologie (Montrouge, France)|November 4, 2021

[HIV1 group M superinfection in a HIV1 group0-infected patient]J-C Plantier, V Lemée, I Dorval, et al.

Hepatology (Baltimore, Md.)|February 1, 1995

Interferon and ursodeoxycholic acid combined therapy in the treatment of chronic viral C hepatitis: results from a controlled randomized trial in 80 patientsE Boucher, H Jouanolle, P Andre, et al.

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1995

Genotypic evolution of HIV-1 isolates from patients after a switch of therapy from zidovudine to didanosineB Masquelier, I Pellegrin, A Ruffault, et al.

Journal of Neurovirology|December 5, 1998

Prevalence of JC virus viraemia in HIV-infected patients with or without neurological disorders: a prospective studyV Dubois, H Moret, M E Lafon, et al.

The Journal of Infectious Diseases|December 9, 2000

JC virus genotypes in France: molecular epidemiology and potential significance for progressive multifocal leukoencephalopathyV Dubois, H Moret, M E Lafon, et al.

Pageof 4